Anesthesia Depth Monitor MGA-06

395000,00
The MGA-06 monitor is a specialized medical device for continuous and objective assessment of anesthesia and sedation depth based on electroencephalogram (EEG) analysis. It is intended for use in operating rooms, intensive care units, and resuscitation departments to enhance patient safety and prevent both under- and over-sedation.

  • Suppression Ratio (SR): indicates the relative duration of EEG suppression periods within the current time interval
  • Electromyographic component level (EMG): reflects electrical activity of facial muscles, helping to distinguish artifacts from true EEG signals
  • Electrode impedance (Z1, Z2, Z3): allows assessment of electrode-skin contact quality

Type: Anesthesia Depth Monitor

Country of origin: Russia

Brand: Triton

Description
Specifications

Description

The MGA-06 monitor is a specialized medical device for continuous and objective assessment of anesthesia and sedation depth based on electroencephalogram (EEG) analysis. It is intended for use in operating rooms, intensive care units, and resuscitation departments to enhance patient safety and prevent both under- and over-sedation.
The primary parameter calculated by the monitor is the Brain Activity Index (AI), which reflects the degree of consciousness suppression induced by anesthetic and sedative agents. The analysis algorithm accounts for typical EEG changes, including:
  • Narrowing of the spectral bandwidth due to a decrease in high-frequency components and an increase in low-frequency components
  • Increased spectral irregularity
  • Reduction in electromyographic (EMG) activity of facial muscles

Specifications

In addition to the AI, the device displays the following parameters:
  • EEG Suppression Ratio (SR) — indicates the relative duration of EEG suppression periods within the current time interval;
  • Electromyographic component level (EMG) — reflects electrical activity of facial muscles, helping to distinguish artifacts from true EEG signals;
  • Electrode impedance (Z1, Z2, Z3) — allows assessment of electrode-skin contact quality.
AI index values are interpreted as follows:
  • 90–100 — awake state;
  • 80–90 — Stage I anesthesia (light sedation): patient opens eyes and maintains eye contact in response to verbal command within 10 seconds or less;
  • 60–80 — Stage II (sedation): eye opening or movement in response to voice or physical stimulation, but no eye contact;
  • 40–60 — Stage III (surgical anesthesia): no response to verbal or physical stimuli — optimal depth for surgery;
  • 30–40 — Stage IV (deep anesthesia): appearance of "burst-suppression" patterns;
  • 20–30 — Stage V: suppression episodes lasting up to 10 seconds;
  • 10–20 — Stage VI: suppression episodes exceeding 10 seconds;
  • 0–10 — Stage VII (very deep anesthesia): suppression accounts for 75% or more of total signal duration, associated with risk of vital function depression.
Advantages:
  • Provides objective, real-time assessment of anesthesia depth;
  • Reduces the risk of intraoperative awareness and anesthetic overdose;
  • Adapts to various classes of anesthetics thanks to an intelligent EEG analysis algorithm;
  • Monitors signal quality via electrode impedance measurement;
  • Enhances safety during both general anesthesia and sedation in patients of all age groups.